Metraipolis › archive › dc_4c706e141ccc
3K3A-Activated Protein C — Wikipedia (en)
- Source
- Wikipedia (en)
- Original
- https://en.wikipedia.org/wiki/3K3A-Activated_Protein_C
- License (as archived)
- CC-BY-SA-4.0
- Archived
- 2026-11-06T15:11:07.731Z
- SHA-256 of the archived text
d1f81ae5e17366ab07b2a1bb262e11f1b9d78447bfd0402d72586915e4d96cb3- Stable URL of this page
https://metraipolis.com/documento/dc_4c706e141ccc
How to cite
3K3A-Activated Protein C — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/3K3A-Activated_Protein_C (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_4c706e141ccc (Metraipolis archive dc_4c706e141ccc, sha256 d1f81ae5e17366ab07b2a1bb262e11f1b9d78447bfd0402d72586915e4d96cb3)
BibTeX
@misc{dc4c706e141ccc,
title = {3K3A-Activated Protein C — Wikipedia (en)},
howpublished = {Wikipedia (en)},
url = {https://en.wikipedia.org/wiki/3K3A-Activated_Protein_C},
note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_4c706e141ccc; sha256 d1f81ae5e17366ab07b2a1bb262e11f1b9d78447bfd0402d72586915e4d96cb3},
year = {2026}
}Archived text
Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/3K3A-Activated_Protein_C. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
3K3A-Activated Protein C (3K3A-APC) is an experimental drug for the treatment of stroke developed by ZZ Biotech, a company founded by Berislav Zlokovic. It is a genetically engineered variant of activated protein C designed to reduce anticoagulant activity while preserving its cytoprotective and anti-inflammatory properties. This recombinant protein is created by substituting three lysine residues with alanines, thereby minimizing the risk of bleeding associated with native activated protein C. 3K3A-APC exerts its therapeutic effects by targeting protease-activated receptor 1 (PAR1) pathway. A Phase 3 clinical trial was scheduled to start when the NIH paused the trial on November 16, 2023, due to concerns about falsification of data in the studies supporting the clinical trial. The drug was also being assessed for the treatment of Alzheimer's disease, and is currently being evaluated by Dermatherix for wound care. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico). Fonte: Wikipedia in inglese, voce «3K3A-Activated Protein C» — https://en.wikipedia.org/wiki/3K3A-Activated_Protein_C Wikidata Q123598631: «experimental drug for the treatment of stroke» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q123598631 Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/3K3A-Activated_Protein_C?action=history). Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza. Estratto dell'introduzione non modificato nel contenuto; revisione 1377648096, consultata il 2026-11-06T15:07:37.137Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 2b27906269438b3658578e6395d81bcc7bd5fd60a94954959bd50ce57a81b1d7